The effect of spraying 0.25% levobupivacaine during endoscopic/ robot thyroidectomy on postoperative pain

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000590

Enrollment

Registered

2012-11-28

Start date

2012-11-15

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug, Procedure/Surgery : Levobupivacaine 0.25% 30 ml (experimental group) or same volume of normal saline (control group)is sprayed just before skin closure in patients with endoscopic or robot-assis

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Endoscopic or Robot-Assisted Thyroidectomy 2) American society of Anesthesiologist physical class I-II 3) Aged 19-70 yrs 4) Informed consent 5) thyroid mass smaller than 4 cm in benign cases and smaller than 2 cm in potentially malignant cases without evidence of extracapsular soft tissue invasion or metastasis

Exclusion criteria

Exclusion criteria: 1) allergy with local anesthetics 2) Chronic user of opioids or analgesics 3) Previous thyroid or thoracic surgery 4) Obesity (BMI = 40 kg/m2) 5) patients who cannot understand pain scale (score) or hard to communicate 6) pregnancy or breast-feeding 7) hepatic or renal insufficiency (estimated glomerular filtration rate < 60 ml/ min/1.73 m2)

Design outcomes

Primary

Measure	Time frame
Postoperative pain (Numerical rating scale)	—

Secondary

Measure	Time frame
adverse effect of local anesthetics (seizure, hypotension, hypertension);PONV, sedation, dizziness, headache;most painful area;consumption of patient-controlled analgesia	—

Countries

Korea, Republic of

Contacts

Public ContactCha Kyong Yom

Seoul National University Bundang Hospital

Outcome results